Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man January 1, 2003
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers June 24, 2002
Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. January 1, 2002
No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study February 1, 2001
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. January 1, 2000
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
